首页> 美国卫生研究院文献>other >Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells
【2h】

Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells

机译:C-Kit +心脏祖细胞产量增加的分离新生大鼠心肌细胞的改进方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell therapy represents a promising new paradigm for treatment of heart disease, a major cause of death in the industrialized world. The recent discovery of tissue resident c-Kit+ cardiac progenitor cells (CPCs) has fueled scientific efforts to exploit these cells therapeutically for regenerative interventions, and primary culture of cardiomyocytes is a common in-vitro model to investigate basic molecular mechanisms underlying cardiac degeneration and regeneration. Current protocols for cardiomyocyte isolation frequently result in low cell yield and insufficient depletion of fibroblasts, which then overgrow the cardiomyocytes in culture. In this protocol we describe an improved method for the isolation of neonatal rat cardiomyocytes that also enables enhanced yields of CPCs. Gentle techniques of enzymatic and mechanical tissue processing ensure high cell numbers and viability, while subsequent Percoll density gradient centrifugation minimizes fibroblasts. We compared the advantages of different enzymes and found that Collagenase 2 alone leads to very high yields of cardiomyocytes, whereas the application of Matrase™ enzyme blend increases the relative yield of c-Kit+ CPCs to up to 35%. Cardiomyocytes and CPCs isolated with this protocol may constitute an important cell source for investigating heart disease as well as cell based therapeutic approaches.
机译:细胞疗法代表了一种有前途的心脏病治疗新模式,心脏病是工业化世界中的主要死亡原因。组织常驻c-Kit +心脏祖细胞(CPC)的最新发现推动了科学努力,以治疗性方式利用这些细胞进行再生干预,而心肌细胞的原代培养是一种常见的体外模型,用于研究心脏变性和再生的基本分子机制。当前用于心肌细胞分离的方案经常导致细胞产量低和成纤维细胞耗竭不足,然后使培养物中的心肌细胞过度生长。在此协议中,我们描述了一种用于分离新生大鼠心肌细胞的改进方法,该方法还可以提高CPC的产量。酶促和机械组织处理的柔和技术可确保高细胞数和活力,而随后的Percoll密度梯度离心可最大程度地减少成纤维细胞。我们比较了不同酶的优势,发现单独的胶原酶2可导致非常高的心肌细胞产量,而Matrase™酶混合物的应用可使c-Kit + CPC的相对产量增加高达35%。用该方案分离的心肌细胞和CPC可能构成用于研究心脏病以及基于细胞的治疗方法的重要细胞来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号